IMPACT HEALTHCARE REIT PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.02 GBX | +0.70% |
|
+0.93% | -1.20% |
| 15/05 | Impact Healthcare REIT Completes Transfer of Three Care Homes in UK | MT |
| 15/05 | Impact Healthcare REIT plc Completes the Transfer of Three Homes Located in Bradford | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 344.5 | 347.7 | 419.4 | 425 | 373.3 | 366.3 | - | - |
| Enterprise Value (EV) 1 | 320.1 | 413.9 | 517 | 539.7 | 373.3 | 550.7 | 558.3 | 569.1 |
| P/E ratio | 10.4 x | 12.1 x | 12.7 x | 24.2 x | 7.64 x | 8.32 x | 7.65 x | 6.96 x |
| Yield | 5.71% | 5.77% | 5.36% | 6.23% | - | 7.92% | 7.98% | 8.26% |
| Capitalization / Revenue | 14.4 x | 11.3 x | 11.5 x | 10.1 x | 7.52 x | 6.62 x | 6.15 x | 5.88 x |
| EV / Revenue | 13.4 x | 13.4 x | 14.2 x | 12.8 x | 7.52 x | 9.96 x | 9.37 x | 9.13 x |
| EV / EBITDA | 16.5 x | 16.1 x | 16.7 x | 15.3 x | 8.83 x | 11.7 x | 10.7 x | 10.5 x |
| EV / FCF | 4,76,75,528 x | 2,14,45,270 x | 2,31,30,657 x | 2,01,16,582 x | - | - | - | - |
| FCF Yield | 0% | 0% | 0% | 0% | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 3,18,954 | 3,18,954 | 3,50,644 | 4,04,764 | 4,14,368 | 4,14,368 | - | - |
| Reference price 2 | 1.080 | 1.090 | 1.196 | 1.050 | 0.9010 | 0.8840 | 0.8840 | 0.8840 |
| Announcement Date | 08/04/20 | 29/03/21 | 29/03/22 | 28/03/23 | 25/03/24 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 23.98 | 30.82 | 36.4 | 42.24 | 49.66 | 55.3 | 59.6 | 62.3 |
| EBITDA 1 | 19.39 | 25.7 | 30.94 | 35.36 | 42.27 | 46.9 | 52 | 54.1 |
| EBIT 1 | 19.39 | 25.7 | 30.94 | 35.36 | 42.27 | 58.5 | 62 | - |
| Operating Margin | 80.86% | 83.41% | 85% | 83.72% | 85.12% | 105.79% | 104.03% | - |
| Earnings before Tax (EBT) 1 | 26.33 | 28.78 | 31.97 | 16.89 | 48.83 | 44.05 | 47.95 | 52.8 |
| Net income 1 | 26.33 | 28.78 | 31.97 | 16.89 | 48.83 | 44.05 | 47.95 | 52.8 |
| Net margin | 109.82% | 93.4% | 87.83% | 39.98% | 98.33% | 79.66% | 80.45% | 84.75% |
| EPS 2 | 0.1037 | 0.0902 | 0.0941 | 0.0433 | 0.1179 | 0.1062 | 0.1155 | 0.1270 |
| Free Cash Flow | 6.715 | 19.3 | 22.35 | 26.83 | - | - | - | - |
| FCF margin | 28% | 62.63% | 61.41% | 63.51% | - | - | - | - |
| FCF Conversion (EBITDA) | 34.63% | 75.08% | 72.24% | 75.86% | - | - | - | - |
| FCF Conversion (Net income) | 25.5% | 67.05% | 69.92% | 158.85% | - | - | - | - |
| Dividend per Share 2 | 0.0617 | 0.0629 | 0.0641 | 0.0654 | - | 0.0700 | 0.0705 | 0.0730 |
| Announcement Date | 08/04/20 | 29/03/21 | 29/03/22 | 28/03/23 | 25/03/24 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 S1 |
|---|---|
| Net sales | - |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income 1 | 27.3 |
| Net margin | - |
| EPS 2 | 0.0726 |
| Dividend per Share | - |
| Announcement Date | 16/08/22 |
1GBP in Million2GBP
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 66.2 | 97.6 | 115 | - | 184 | 192 | 203 |
| Net Cash position 1 | 24.3 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 2.577 x | 3.156 x | 3.243 x | - | 3.932 x | 3.691 x | 3.749 x |
| Free Cash Flow | 6.72 | 19.3 | 22.4 | 26.8 | - | - | - | - |
| ROE (net income / shareholders' equity) | 4.81% | 5.48% | 8.6% | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex | 73.4 | 88.5 | 1.23 | - | - | - | - | - |
| Capex / Sales | 306.18% | 287.21% | 3.38% | - | - | - | - | - |
| Announcement Date | 08/04/20 | 29/03/21 | 29/03/22 | 28/03/23 | 25/03/24 | - | - | - |
1GBP in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.884
GBP
Average target price
1.14
GBP
Spread / Average Target
+28.96%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -1.20% | 47Cr | |
| -7.25% | 1.32TCr | |
| -7.63% | 818.57Cr | |
| -5.58% | 620.64Cr | |
| -6.47% | 559.04Cr | |
| -2.39% | 545.47Cr | |
| +7.36% | 481.04Cr | |
| -9.94% | 453.2Cr | |
| +2.42% | 385.1Cr | |
| -13.83% | 315.93Cr |
- Stock Market
- Equities
- IHR Stock
- Financials Impact Healthcare REIT PLC